The Food and Drug Administration has announced a nationwide recall of atorvastatin calcium tablets, a generic version of the widely used cholesterol-lowering drug Lipitor, after lab tests showed the ...

The FDA banned the Indian manufacturing plant where Ranbaxy Laboratories made its generic version of Lipitor last year after citing the plant for a list of problems. The year before, the drugmaker ...

The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...

Ranbaxy Laboratories, which is reeling under regulatory action from the U.S. Food and Drug Administration (USFDA), has recalled more than 64,000 bottles of Atorvastatin calcium tablets, a generic ...

More than 140,000 bottles of a widely prescribed cholesterol medication have been pulled from the market after failing to meet quality standards. Ascend Laboratories of New Jersey issued the recall ...

The US Food and Drug Administration (FDA) has issued an urgent nationwide recall of more than 140,000 bottles of Atorvastatin Calcium tablets, a generic version of the popular cholesterol drug Lipitor ...

A drug taken daily by millions of Americans has been recalled nationwide after federal regulators said it failed quality testing. The recall affects more than 141,000 bottles of Atorvastatin Calcium ...

Ezetimibe/simvastatin: 10/10 mg, 10/20 mg, 10/40 mg, and 10/80 mg. Atorvastatin: 10 mg, 20 mg, 40 mg, and 80 mg. The primary end point of the study was the percent change from baseline to the end of ...

The National Pharmaceutical Pricing Authority (NPPA) has released the recalculated ceiling price of cholesterol lowering drug atorvastatin 10 mg as per the instructions of the review authority under ...